期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 17, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/ijms17050714
关键词
drug-induced liver injury; DILI; risk factors
资金
- Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional-FEDER [PI12/00378, SAS-PI-0239/2012, AC-0073-2013]
- Agencia Espanola del Medicamento
- Instituto de Salud Carlos III
Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) presents with a range of both phenotypes and severity, from acute hepatitis indistinguishable of viral hepatitis to autoimmune syndromes, steatosis or rare chronic vascular syndromes, and from asymptomatic liver test abnormalities to acute liver failure. DILI pathogenesis is complex, depending on the interaction of drug physicochemical properties and host factors. The awareness of risk factors for DILI is arising from the analysis of large databases of DILI cases included in Registries and Consortia networks around the world. These networks are also enabling in-depth phenotyping with the identification of predictors for severe outcome, including acute liver failure and mortality/liver transplantation. Genome wide association studies taking advantage of these large cohorts have identified several alleles from the major histocompatibility complex system indicating a fundamental role of the adaptive immune system in DILI pathogenesis. Correct case definition and characterization is crucial for appropriate phenotyping, which in turn will strengthen sample collection for genotypic and future biomarkers studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据